Jump to content

TYK309: Difference between revisions

From PedsAnesthesiaNet
m 1 revision imported
m Text replacement - "<p style="text-align: center;"> About Test Your Knowledge</p>" to "<p style="text-align: center;"> About Test Your Knowledge</p> Category:TYK"
 
Line 33: Line 33:
<p style="text-align: center;">[[TYK308|<Prev Question]] --- [[TYK310|Next Question>]]</p>
<p style="text-align: center;">[[TYK308|<Prev Question]] --- [[TYK310|Next Question>]]</p>
<p style="text-align: center;">[[TYK About | About Test Your Knowledge]]</p>
<p style="text-align: center;">[[TYK About | About Test Your Knowledge]]</p>
[[Category:TYK]]

Latest revision as of 02:48, 25 September 2026

Which of the following is FALSE regarding mineralocorticoids?

a) Mineralocorticoids are primarily produced in the zona glomerulosa.

b) ACE-inhibitors promote the conversion of corticosterone to aldosterone.

c) Aldosterone increases sodium reabsorption in the renal principle cells of late distal tubule and collecting duct

d) Decreased renal perfusion pressure is a potent stimulant of aldosterone secretion.

e) Mineralocorticoid activity is regulated by a hormone produced in the kidney.

Click for Answer

Answer

Answer b. Angiotensin II is responsible for the conversion of corticosterone to aldosterone in the zona glomerulosa; thus, ACE-inhibitors, which prevent conversion of Angiotensin I to Angiotensin II, will inhibit the production of aldosterone. The renin-angiotensin-aldosterone system is regulated by renin, a hormone released by the juxtaglomerular apparatus in the kidney in response to hyponatremia, hypotension, or adrenergic stimulation.

Notes

This question originally printed in the Pediatric Anesthesiology Review Topics kindle book series, and appears courtesy of Naerthwyn Press, LLC.

Keywords



<Prev Question --- Next Question>

About Test Your Knowledge